Blackstone, Carlyle and Hellman & Friedman funds are acquiring a majority stake in Medline, which manufactures and sells medical products worldwide. Financial terms were not disclosed. According to The Wall Street Journal, the deal could be worth about $34 billion. The deal is scheduled to close in late 2021.